Thailand In Vivo Cro Market Size & Outlook, 2024-2030
Related Markets
Thailand in vivo cro market highlights
- The Thailand in vivo cro market generated a revenue of USD 26.0 million in 2023 and is expected to reach USD 44.5 million by 2030.
- The Thailand market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
In vivo cro market data book summary
| Market revenue in 2023 | USD 26.0 million |
| Market revenue in 2030 | USD 44.5 million |
| Growth rate | 7.9% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, Thailand accounted for 0.6% of the global in vivo cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 122.7 million by 2030.
Small molecule was the largest segment with a revenue share of 63.85% in 2024. Horizon Databook has segmented the Thailand in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Thailand has a well-developed healthcare infrastructure and a robust regulatory framework to ensure ethical conduct and patient safety in preclinical studies. The country has implemented several guidelines and standards that align with international best practices, providing confidence to sponsors and regulatory bodies.
Furthermore, the country’s diverse population and extensive range of animal models make it an ideal location for conducting in vivo studies. The availability of various genetic backgrounds and disease models allows researchers to simulate human conditions accurately, enhancing the relevance and reliability of their research outcomes.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Thailand in vivo cro market size, by modality type, 2018-2030 (US$M)
Thailand In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
